Luis Javier Herrera
Orlando Health, Beth Israel Deaconess Medical Center, Universidad de Granada
Papers
13
Total Citations
285
H-Index
8
About
Luis Javier Herrera has established himself as a leading voice in thoracic surgery, with a particular focus on minimally invasive and robotic-assisted approaches to lung cancer treatment. His research centers on comparative surgical outcomes, cost-effectiveness, and the clinical adoption of emerging operative technologies, most notably robotic-assisted thoracoscopic surgery (RATS) for pulmonary lobectomy. Herrera is perhaps best known as a principal investigator of the landmark Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study, a multi-institutional effort that has generated three major publications collectively amassing over 175 citations. This body of work has provided some of the most rigorous comparative data available on open, VATS, and robotic lobectomy, including overall survival analyses and conversion risk factors—directly informing surgical decision-making worldwide. His 2020 economic comparative effectiveness study further positioned him at the intersection of clinical outcomes and healthcare value. With documented experience across more than 2,500 robotic cases, Herrera has also contributed programmatic insights into building RATS infrastructure and optimizing surgical costs. His ongoing evaluation of next-generation robotic platforms, including the da Vinci IS5000, signals continued engagement at the frontier of surgical innovation, making his work essential reading for surgeons and health systems navigating the evolving landscape of lung cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study119 citations · 2021
- 2
- 3Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study30 citations · 2023
- 4
- 5
- 6
- 7
- 8
- 9
- 10